Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A new twist on superantigen-activated autoimmune disease
Andrew L. Mason, Doaa Waly, Mohammed S. Osman
Andrew L. Mason, Doaa Waly, Mohammed S. Osman
View: Text | PDF
Commentary

A new twist on superantigen-activated autoimmune disease

  • Text
  • PDF
Abstract

Superantigen-induced (Sag-induced) autoimmunity has been proposed as a mechanism for many human disorders, without a clear understanding of the potential triggers. In this issue of the JCI, McCarthy and colleagues used the SKG mouse model of rheumatoid arthritis to characterize the role of Sag activity in inflammatory arthritis by profiling arthritogenic naive CD4+ T cells. Within the diseased joints, they found a marked enrichment of T cell receptor–variable β (TCR-Vβ) subsets that were reactive to the endogenously encoded mouse mammary tumor virus (MMTV) Sag. Arthritis was improved using reverse transcriptase inhibitors. Moreover, depletion of MMTV Sag-activated TCR-Vβ subsets affected the ability of transferred activated CD4+ T cells to induce disease in mice with severe combined immunodeficiency (SCID). Further virological studies should determine whether endogenous or exogenous MMTV is necessary or sufficient to trigger inflammatory arthritis in the SKG model.

Authors

Andrew L. Mason, Doaa Waly, Mohammed S. Osman

×

Figure 1

The SKG mouse model of RA supports an endogenous and/or exogenous MMTV Sag-driven autoimmune response.

Options: View larger image (or click on image) Download as PowerPoint
The SKG mouse model of RA supports an endogenous and/or exogenous MMTV S...
T cells develop in the thymus and progress through positive and negative selection. (A) In WT BALB/c mice, thymocytes that react with endogenous MMTV encoded Sags are actively deleted. (B) In contrast, the SKG mouse model with a hypomorphic ZAP-70 protein results in positively selected Sag-reactive and autoimmune T cells that have impaired signaling downstream of the TCR/peptide-MHC complex. (C) Sags may promote arthritis via two potential models: (i) In the periphery, endogenously encoded Mtv Sag activates cognate TCR-Vβ subsets, and these autoimmune naive arthritogenic CD4+ T cells home to SKG joints to initiate disease; or (ii) exogenous MMTV arises as a result of resurrected endogenous retroelements in the setting of immunodeficiency and replicates in proliferating cognate TCR-Vβ T cells activated by viral Sags. These lymphocytes home to infect joints, where autoimmune and CD8+ cytotoxic T cell responses to MMTV instigate arthritis. pMHC, peptide MHC.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts